Current Vascular Pharmacology : Impact Factor & More
eISSN: 1875-6212pISSN: 1570-1611
Share this on:
Key Metrics
CiteScore 
6.3
H-Index
67
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
0.8
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Current Vascular Pharmacology
Current Vascular Pharmacology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2003 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Vascular Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Vascular Pharmacology
Anticoagulation in the Aging Brain: Navigating the Intersection of Dementia, Cerebrovascular Risk, and Therapeutic Uncertainty.
- 21 Jul 2026
- Current vascular pharmacology
Pericarditis/Myopericarditis/Pericardial Effusion: A Contemporary Approach to Diagnosis and Management.
- 17 Jul 2026
- Current vascular pharmacology
Postprandial Triglycerides and Residual Cardiovascular Risk: Rethinking Lipid-Lowering Strategies.
- 8 Jul 2026
- Current vascular pharmacology
Chronic Treatment with Renin-Angiotensin System Inhibitors at Hospital Admission is Associated with Improved Reperfusion and Mortality Among STEMI Patients Undergoing Mechanical Reperfusion: Insight from the ISACS-STEMI COVID-19 Registry.
- 6 Jul 2026
- Current vascular pharmacology
Steps to Walk Out of, or Side Track, Cardiovascular Disease to Achieve Longevity.
- 3 Jul 2026
- Current vascular pharmacology
Mast Cells and Cardiovascular Disorders.
- 18 Jun 2026
- Current vascular pharmacology
Anticoagulation in the Aging Brain: Navigating the Intersection of Dementia, Cerebrovascular Risk, and Therapeutic Uncertainty.
- 21 Jul 2026
- Current vascular pharmacology
Pericarditis/Myopericarditis/Pericardial Effusion: A Contemporary Approach to Diagnosis and Management.
- 17 Jul 2026
- Current vascular pharmacology
Postprandial Triglycerides and Residual Cardiovascular Risk: Rethinking Lipid-Lowering Strategies.
- 8 Jul 2026
- Current vascular pharmacology
Chronic Treatment with Renin-Angiotensin System Inhibitors at Hospital Admission is Associated with Improved Reperfusion and Mortality Among STEMI Patients Undergoing Mechanical Reperfusion: Insight from the ISACS-STEMI COVID-19 Registry.
- 6 Jul 2026
- Current vascular pharmacology
Steps to Walk Out of, or Side Track, Cardiovascular Disease to Achieve Longevity.
- 3 Jul 2026
- Current vascular pharmacology
Mast Cells and Cardiovascular Disorders.
- 18 Jun 2026
- Current vascular pharmacology
FAQs on Current Vascular Pharmacology
How long has Current Vascular Pharmacology been actively publishing? 
What is the publishing frequency of Current Vascular Pharmacology?
How many articles did Current Vascular Pharmacology publish last year?
What is the eISSN & pISSN for Current Vascular Pharmacology?
What is Citescore for Current Vascular Pharmacology?
What is the H Index for Current Vascular Pharmacology ?
What is SNIP score for Current Vascular Pharmacology?
What is the SJR for Current Vascular Pharmacology?
Who is the publisher of Current Vascular Pharmacology?
